8-10
Jul
2026
6-8
Oct
2026
14-16
Dec
2026
CPHI Middle East 2026
Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
H1.C35
Polifarma
About Polifarma
Certifications
-
CE -
GMP -
ISO
Categories
Meet us at
-
CPHI South East Asia 2026
QSNCC, Bangkok, Thailand
08 Jul 2026 - 10 Jul 2026 -
CPHI Milan 2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026 -
CPHI Middle East 2026
Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
14 Dec 2026 - 16 Dec 2026
-
Country/Region:Türkiye
-
On CPHI since:2015
-
Certificates:3
-
Employees:1000 - 4999
Company types
Primary activities
Contact info
-
-
-
Halkali Merkez Mahallesi, Basin Ekspres Caddesi, Capital Tower no 9 kat 6, 34303, Istanbul, Türkiye
Products from Polifarma (61)
-
Product ASIMPLEX 250 MG LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION
Herpes simplex infections in immunosuppressed patients: ASIMPLEX is indicated for the treatment of initial and recurrent cutaneous and mucosal herpes simplex (HSV1 and HSV2) in immunocompromised individuals and immunosuppressed patients.
In initial infection of genital herpes: ASIMPLE... -
Product BRADIKANT 30 MG/3 ML SOLUTION FOR S.C. INJECTION IN PRE-FILLED SYRINGE
BRADIKANT is indicated for symptomatic treatment of acute attacks of hereditary
angioedema (HAE) in adults, adolescents and children aged 2 years and older, with C1-esterase-inhibitor deficiency. -
Product CORTİPOL 250 Mg I.M./ I.V. POWDER AND SOLVENT FOR PREPARING INJECTION SOLUTION
Active Ingredient: Methyl Prednisolone Sodium Succinate
Therapeutic Area: ANTIRHEUMATIC -
Product MUSCOBLOC 50 mg/ml I.V. Solution for injection - 5 Vials
Active Ingredient: ROCURONIUM BROMIDE
Therapeutic Area: MUSCLE RELAXANT -
Product VANKOPOL 1000 mg IV Lyophilized powder for infusion and oral solution preparation - 1 vial
Active Ingredient: VANCOMIYCIN SODIUM
Therapeutic Area: ANTIBIOTIC -
Product NUSINERSEN
Nusinersen sodium is indicated for the treatment of SMA (Spinal Muscular Atrophy). -
Product CYSMIN
CYSTEAMINE Ophthalmology.3,8 mg/mL
CYSTEAMINE HYDROCHLORIDE is indicated for the treatment of corneal cystine crystal deposits in adults and children from 2 years of age with cystinosis. -
Product VANKOPOL 500 mg IV Lyophilized powder for infusion and oral solution preparation - 1 vial
Active Ingredient: VANCOMIYCIN SODIUM
Therapeutic Area: ANTIBIOTIC -
Product TEİKOPOL 400 mg I.M./I.V. Powder and solvent for preparation of injectable solution
Active Ingredient: TEIKOPLANIN
Therapeutic Area: ANTIBIOTIC -
Product TEİKOPOL 200 mg I.M./I.V. Powder and solvent for preparation of injectable solution
Active Ingredient: TEIKOPLANIN
Therapeutic Area: ANTIBIOTIC
-
Product TYGEPOL 50 mg IV lyophilized powder for infusion solution
Active Ingredient: TIGECYCLINE
Therapeutic Area: ANTIBIOTIC
10 VIALS -
Product VORİKANDİN 200 mg IV
Active Ingredient: VORICONAZOLE
Therapeutic Area: ANTI-FUNGAL
Polifarma Resources (2)
-
Video Corporate Introductory Video
Polifarma's Corporate Video -
Brochure Product list
Product list